Form D · Biotechnology
PHOENIX BIOTECHNOLOGY INC
San Antonio, TX · CIK 0001278815
Offering snapshot reported Aug 17, 2020 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5M Reported outside-investor minimum
- First sale
- Aug 7, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2020 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Oct 16, 2019 | Amendment | $1,760,700 | $881,700vs Oct 18, 2018 | 25 | SEC filing |
| Jan 9, 2019 | Amendment | $1,045,200 | $166,200vs Oct 18, 2018 | 19 | SEC filing |
| Oct 18, 2018 | Initial | $879,000 | No comparison | 12 | SEC filing |
| Jun 18, 2014 | Initial | $852,000 | No comparison | 23 | SEC filing |
| Dec 29, 2010 | Amendment | $3,300,664 | $104,000vs Nov 4, 2010 | 65 | SEC filing |
| Nov 4, 2010 | Amendment | $3,196,664 | $488,400vs Oct 7, 2010 | 62 | SEC filing |
| Oct 7, 2010 | Amendment | $2,708,264 | $1,587,664vs Sep 10, 2010 | 54 | SEC filing |
| Sep 10, 2010 | Amendment | $1,120,600 | $719,000vs Aug 30, 2010 | 30 | SEC filing |
| Aug 30, 2010 | Initial | $401,600 | No comparison | 11 | SEC filing |
| Sep 24, 2008 | Paper | Not reported | No comparison | Not reported | |
| Jan 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373409
Source: Form D, filed Aug 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Crandell Addington | Director, Executive |
| Andrew J. Butler | Director |
| John W. Creamer | Director |
| Macdonald T. Haskell | Director |
| Lou Kost | Director, Executive |
| Lou Kost, Jr. | Director, Executive |
| Robert A. Newman | Director, Executive |
| Jeffrey S. Thompson | Director |
| Carlos Torres | Executive |
| Andrew Whitney | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8626 Tesoro Dr Suite 801
San Antonio, TX, 78217
San Antonio, TX, 78217